Several epidemiological studies have demonstrated a significantly increased risk for developing PD in individuals with central obesity [189, 190], an important result because IGF-1 and insulin signaling pathways are known to be dysregulated under metabolic derangements [54]. This evidence concerns the gene IGF1 and Parkinson disease.